colforsin has been researched along with hexacyanoferrate iii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekmekcioglu, C; Marktl, W; Strauss-Blasche, G | 1 |
| Gupte, SA; Phillibert, D; Rupawalla, T; Wolin, MS | 1 |
2 other study(ies) available for colforsin and hexacyanoferrate iii
| Article | Year |
|---|---|
The plasma membrane Fe(3+)-reductase activity of Caco-2 cells is modulated during differentiation.
Topics: Alkaline Phosphatase; Bucladesine; Caco-2 Cells; Cell Differentiation; Cell Division; Colforsin; Culture Media, Serum-Free; Ferric Compounds; Ferricyanides; FMN Reductase; Humans; Insulin; Microvilli; Mitomycin; NAD; NADH, NADPH Oxidoreductases; Nitrilotriacetic Acid; Oxidation-Reduction; Phenylephrine; Sucrase; Triiodothyronine | 1998 |
NADPH and heme redox modulate pulmonary artery relaxation and guanylate cyclase activation by NO.
Topics: Animals; Cattle; Colforsin; Cyclic GMP; Electron Transport; Enzyme Activation; Enzyme Inhibitors; Ferricyanides; Flavoproteins; Glutathione; Guanylate Cyclase; Heme; In Vitro Techniques; NADH, NADPH Oxidoreductases; NADP; Nitric Oxide; Oxadiazoles; Oxidation-Reduction; Penicillamine; Pentose Phosphate Pathway; Pulmonary Artery; Quinoxalines; Reactive Oxygen Species; Sulfhydryl Compounds | 1999 |